Abbott Laboratories Stock Rises on Strong Q2 Results and Raised Earnings Outlook
Shares of Abbott Laboratories (ABT) surged after the company reported a 13% sales increase in its second quarter, driven by the acquisition of Exact Sciences. The firm raised its full-year adjusted earnings per share forecast to $5.45-$5.60 and expects strong growth from diagnostics and medical devices.
